Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study …

Overview of attention for article published in BMC Infectious Diseases, July 2018

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 1,258 followers.

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibito... https://t.co/uMMqDJbjed #bmcinfectdis

Improvement of lipid profile after switching from EFV or PI/rtv... https://t.co/GBM0OqSx10 #bmcinfectdis

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibito... https://t.co/GBM0OqSx10 #bmcinfectdis

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.